Bridgeway Capital Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Bridgeway Capital Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-366,751	Closed	-$3.19M	–	1511
2018 Q2	$3.19M	Buy	366,751 +9,151	+3%	+$82.3K	0.03%	458
2018 Q1	$3.63M	Hold	357,600	–	–	0.04%	381
2017 Q4	$1.73M	Buy	357,600 +61,800	+21%	+$300K	0.02%	643
2017 Q3	$1.35M	Buy	295,800 +83,100	+39%	+$390K	0.02%	737
2017 Q2	$1.07M	Buy	212,700 +32,500	+18%	+$145K	0.01%	796
2017 Q1	$856K	Hold	180,200	–	–	0.01%	870
2016 Q4	$1.01M	Hold	180,200	–	–	0.01%	822
2016 Q3	$1M	Hold	180,200	–	–	0.01%	793
2016 Q2	$1.26M	Buy	180,200 +38,350	+27%	+$270K	0.02%	691
2016 Q1	$938K	Buy	141,850 +40,950	+41%	+$301K	0.02%	795
2015 Q4	$1.04M	Buy	+100,900	New	+$1.17M	0.02%	742

Bridgeway Capital Management's JNP Position: Q3 2018 in Review

Bridgeway Capital Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 366,751 shares — an estimated $3.19M sold.

Bridgeway Capital Management first reported a position in JNP in Q4 2015 and held it in 11 quarters. The position peaked at $3.63M in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Bridgeway Capital Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Bridgeway Capital Management sold 366,751 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $3.19M.
Bridgeway Capital Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2015 and held it in 11 quarters.
Bridgeway Capital Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $3.63M in Q1 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Bridgeway Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.